SCHEMBL30037705

SCHEMBL30037705

Cc1cc(Br)c(C)nc1N

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.44
ALDH1A1 P00352 2/20 0.41
HPGD P15428 2/20 0.41
APOBEC3G Q9HC16 1/20 0.41
NOS3 P29474 2/20 0.38
NOS1 P29475 2/20 0.38
NOS2 P35228 2/20 0.38
TERT O14746 1/20 0.37
TSHR P16473 3/20 0.35
MAPK1 P28482 2/20 0.35
CYP3A4 P08684 2/20 0.35
HTT P42858 3/20 0.33
KMT2A Q03164 2/20 0.33
KDM4E B2RXH2 2/20 0.33
UHRF1 Q96T88 1/20 0.33
MEN1 O00255 1/20 0.33
NQO2 P16083 1/20 0.33
BACE1 P56817 1/20 0.33
TDP1 Q9NUW8 1/20 0.31
NQO1 P15559 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7002357 1.00 LMNA (0.44) LMNAALDH1A1HPGDAPOBEC3GNOS3
SCHEMBL29693601 0.83 LMNA (0.46) LMNAALDH1A1HPGDAPOBEC3GNOS3
SCHEMBL2401968 0.83 LMNA (0.46) LMNAALDH1A1HPGDAPOBEC3GNOS3
SCHEMBL17298243 0.81 NOS3 (0.38) LMNAALDH1A1HPGDAPOBEC3GNOS3
SCHEMBL6635851 0.81 LMNA (0.44) LMNAALDH1A1HPGDAPOBEC3GNOS3
SCHEMBL1565399 0.81 LMNA (0.44) LMNAALDH1A1HPGDAPOBEC3GNOS3
SCHEMBL29693617 0.81 LMNA (0.44) LMNAALDH1A1HPGDAPOBEC3GNOS3
SCHEMBL22246500 0.77 NOS3 (0.35) LMNAALDH1A1NOS3NOS1NOS2
SCHEMBL21047969 0.77 LMNA (0.41) LMNAALDH1A1HPGDAPOBEC3GTERT
SCHEMBL15538252 0.77 LMNA (0.41) LMNAALDH1A1HPGDAPOBEC3GCYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-RE49931-E1 [1,2,4]triazolo[1,5-a]pyridinyl substituted indole compounds BRISTOL-MYERS SQUIBB COMPANY (US) 2024-04-23 US disclosed
US-RE49893-E1 [1,2,4]triazolo[1,5-a]pyridinyl substituted indole compounds BRISTOL-MYERS SQUIBB COMPANY (US) 2024-04-02 US disclosed
US-RE49880-E1 [1,2,4]triazolo[1,5-a]pyridinyl substituted indole compounds BRISTOL-MYERS SQUIBB COMPANY (US) 2024-03-26 US disclosed
US-11672780-B2 [1,2,4]triazolo[1,5-a]pyridinyl substituted indole compounds BRISTOL-MYERS SQUIBB COMPANY (US) 2023-06-13 US disclosed
CN-110997670-B [1,2,4] triazolo [4,3-a ] pyridyl substituted indole compounds 百时美施贵宝公司 2022-11-01 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11672780-B2 [1,2,4]triazolo[1,5-a]pyridinyl substituted indole compounds TLR7, TLR1, TLR5 LMNA 2619/4885ALDH1A1 1780/4885HPGD 2042/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.